Specific Focus on Clinical Cardiovascular Pharmacology
The European Heart Journal – Cardiovascular Pharmacotherapy (EHJ-CVP) is the official journal of the European Society of Cardiology and the ESC Working Group on Cardiovascular Pharmacotherapy. The journal reports on the interpretation and integration of new scientific developments to improve the pharmacological treatment of patients with cardiovascular disease.
It publishes original articles on clinical research, with new and established drugs and methods, as well as meta-analysis and topical reviews.
Double vs. triple antithrombotic therapy in atrial fibrillation patients undergoing percutaneous coronary intervention: does clinical presentation matter?
Author(s):Rubboli A, Collet J.
25 Jan 2021
Real-world safety and efficacy of direct oral anticoagulants in atrial fibrillation: a systematic review and meta-analysis of 605 771 patients
Author(s):Menichelli D, Del Sole F, Di Rocco A, et al.
29 Oct 2020
Safety and efficacy of double vs. triple antithrombotic therapy in patients with atrial fibrillation with or without acute coronary syndrome undergoing percutaneous coronary intervention: a collaborative meta-analysis of non-vitamin K antagonist oral anticoagulant-based randomized clinical trials
Author(s):Gargiulo G, Cannon C, Gibson C, et al.
Our mission: To reduce the burden of cardiovascular disease.